New treatment option for Shoulder Osteoarthritis
Official title Rehabilitation Following Reverse Total Shoulder Arthroplasty
ClinicalTrials.gov ID: NCT03804853
What this study is testing
- What it's testing
- Reverse total shoulder arthroplasty (RTSA) has been successful in patients with rotator cuff arthropathy, proximal humerus fractures, failed primary total shoulder arthroplasty or failed hemiarthroplasty, and massive irreparable rotator cuff tear. Patients who undergo an RTSA report pain relief and functional range of motion.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 and older
You may be able to join if
- \> 55 years of age.
- Candidate for a primary reverse total shoulder arthroplasty.
- Capable of completing self-administered questionnaires.
- Be willing and able to return for all study-related follow-up procedures.
- Able and willing to give informed consent.
You likely can't join if
- In-Clinic:
- Patients planning on undergoing a Primary Reverse Shoulder Total Arthroplasty due to proximal humeral fracture.
- Previous shoulder surgery including previous total shoulder arthroplasty or reverse total shoulder arthroplasty or hemiarthroplasty, or instability...
- Active bacterial infection of the shoulder.
- Any concomitant shoulder procedure.
- Additional ipsilateral or contralateral upper limb pathology that requires active treatment (i.e. surgery or brace).
See the full eligibility criteria
- \> 55 years of age.
- Candidate for a primary reverse total shoulder arthroplasty.
- Capable of completing self-administered questionnaires.
- Be willing and able to return for all study-related follow-up procedures.
- Able and willing to give informed consent.
- Proficient in the English language.
- In-Clinic:
- Patients planning on undergoing a Primary Reverse Shoulder Total Arthroplasty due to proximal humeral fracture.
- Previous shoulder surgery including previous total shoulder arthroplasty or reverse total shoulder arthroplasty or hemiarthroplasty, or instability repairs
- Active bacterial infection of the shoulder.
- Any concomitant shoulder procedure.
- Additional ipsilateral or contralateral upper limb pathology that requires active treatment (i.e. surgery or brace).
- Inflammatory arthropathy.
- Diagnosed with Rheumatoid arthritis
- Diagnosed with gout.
- Subject is on chronic anticoagulation due to a bleeding disorder or has taken anticoagulants within 10 days prior to surgery.
- Peripheral vascular disease or other vascular disorders that would impair healing.
- Peripheral neuropathy or other neurological disorders that may impair the patient to ambulate.
- Patient is on workers compensation.
- Any condition requiring chemotherapy.
- Active tobacco user or former tobacco user who is not free of using tobacco for 8 weeks.
- Uncontrolled Diabetes Mellitus with an HbA1C \> 7.5%.
- Current drug or alcohol abuse.
- Major medical illness (life expectancy less then 2 years or unacceptably high operative risk)
- Suspicion of cervical radiculopathy or myelopathy.
- Deltoid insufficiency on physical examination. Intra-operative:
- Iatrogenic glenoid fracture Post-operative:
- Neurological injury of the upper extremity.
- Complications from Primary Reverse Shoulder Total Arthroplasty (i.e. post-operative infection, bleeding, hardware failure).
The study team makes the final eligibility decision.
Where it's taking place
- Bloomington, Minnesota, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bloomington, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.